221 related articles for article (PubMed ID: 16738903)
1. Psoriasis onset during infliximab treatment: description of two cases.
Volpe A; Caramaschi P; Carletto A; Pieropan S; Bambara LM; Biasi D
Rheumatol Int; 2006 Oct; 26(12):1158-60. PubMed ID: 16738903
[TBL] [Abstract][Full Text] [Related]
2. Pustular skin lesions in patients treated with infliximab: report of two cases.
Starmans-Kool MJ; Peeters HR; Houben HH
Rheumatol Int; 2005 Sep; 25(7):550-2. PubMed ID: 15711788
[TBL] [Abstract][Full Text] [Related]
3. Infliximab-induced palmoplantar psoriasis in a patient with ankylosing spondylitis.
Capkin E; Karkucak M; Yayli S; Aydin Çapkin A; Tosun M
J Clin Rheumatol; 2011 Aug; 17(5):293-4. PubMed ID: 21808187
[No Abstract] [Full Text] [Related]
4. Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?
Rossini M; Viapiana O; Orsolini G; Fracassi E; Idolazzi L; Gatti D; Adami S; Govoni M
Reumatismo; 2015 Mar; 66(4):285-303. PubMed ID: 25829189
[TBL] [Abstract][Full Text] [Related]
5. Psoriasis induced by infliximab in a Saudi patient with ankylosing spondylitis.
Alabed IB; Qushmaq KA; Khan MA
Saudi Med J; 2010 Sep; 31(9):1054-6. PubMed ID: 20844821
[TBL] [Abstract][Full Text] [Related]
6. [Effectiveness and safety of biological therapy with adalimumab].
Fehér J; Lengyel G
Orv Hetil; 2009 Jun; 150(26):1215-22. PubMed ID: 19546078
[TBL] [Abstract][Full Text] [Related]
7. Development of new-onset psoriasis in a patient receiving infliximab for treatment of rheumatoid arthritis.
Chan CY; Browning JC; Larsen F; Hsu S
Dermatol Online J; 2008 Sep; 14(9):12. PubMed ID: 19061594
[TBL] [Abstract][Full Text] [Related]
8. Anti-TNFalpha: a new dimension in the pharmacotherapy of the spondyloarthropathies !?
Braun J; Sieper J
Ann Rheum Dis; 2000 Jun; 59(6):404-7. PubMed ID: 10834852
[No Abstract] [Full Text] [Related]
9. Infliximab for psoriasis and psoriatic arthritis.
Antoni C; Manger B
Clin Exp Rheumatol; 2002; 20(6 Suppl 28):S122-5. PubMed ID: 12463461
[TBL] [Abstract][Full Text] [Related]
10. Infection relapse in spondyloarthritis treated with biological drugs: a single-centre study.
Modesti V; Ramonda R; Ortolan A; Lorenzin M; Lo Nigro A; Frallonardo P; Oliviero F; Campana C; Punzi L
Scand J Rheumatol; 2012; 41(6):490-1. PubMed ID: 22985209
[No Abstract] [Full Text] [Related]
11. Annual acquisition and administration cost of biologic response modifiers per patient with rheumatoid arthritis, psoriasis, psoriatic arthritis, or ankylosing spondylitis.
Bonafede M; Joseph GJ; Princic N; Harrison DJ
J Med Econ; 2013 Sep; 16(9):1120-8. PubMed ID: 23808901
[TBL] [Abstract][Full Text] [Related]
12. Infliximab monotherapy for refractory psoriasis: preliminary results.
Cassano N; Loconsole F; Amoruso A; Coviello C; Filieri M; Filotico R; Del Vecchio S; Vena GA
Int J Immunopathol Pharmacol; 2004; 17(3):373-80. PubMed ID: 15461871
[TBL] [Abstract][Full Text] [Related]
13. [Treatment outcome of spondyloarthropathy with infliximab].
Głowska A; Wiland P; Szechiński J
Pol Arch Med Wewn; 2005 Jan; 113(1):42-7. PubMed ID: 16130600
[TBL] [Abstract][Full Text] [Related]
14. Acquired erythrocytosis upon treatment with infliximab for ankylosing spondylitis.
Antonelli M; Bupathi M; Janakiram M; Hergenroeder P; Khan MA
J Rheumatol; 2011 Mar; 38(3):581-3. PubMed ID: 21362796
[No Abstract] [Full Text] [Related]
15. Two-year retention rate of golimumab in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis: data from the LORHEN registry.
Manara M; Caporali R; Favalli EG; Grosso V; Atzeni F; Sarzi Puttini P; Gorla R; Bazzani C; Fusaro E; Pellerito R; Rocchetta PA; Sinigaglia L
Clin Exp Rheumatol; 2017; 35(5):804-809. PubMed ID: 28770712
[TBL] [Abstract][Full Text] [Related]
16. Drug-induced lupus-like syndrome in ankylosing spondylitis treated with infliximab.
Mounach A; Ghazi M; Nouijai A; Ghozlani I; Achemlal L; Bezza A; El Maghraoui A
Clin Exp Rheumatol; 2008; 26(6):1116-8. PubMed ID: 19210883
[TBL] [Abstract][Full Text] [Related]
17. Exacerbation of infliximab-induced palmoplantar psoriasis under ustekinumab therapy in a patient with ankylosing spondylitis.
Safa G; Martin A; Darrieux L
J Clin Rheumatol; 2011 Oct; 17(7):385-6. PubMed ID: 21946468
[No Abstract] [Full Text] [Related]
18. Treatment of rheumatic inflammatory disease in 25 patients with secondary amyloidosis using tumor necrosis factor alpha antagonists.
Fernández-Nebro A; Tomero E; Ortiz-Santamaría V; Castro MC; Olivé A; de Haro M; Portales RG; González-Mari MV; Laffón A; García-Vicuña R
Am J Med; 2005 May; 118(5):552-6. PubMed ID: 15866260
[No Abstract] [Full Text] [Related]
19. Once-a-month injection approved to treat three types of arthritis.
Thompson CA
Am J Health Syst Pharm; 2009 Jun; 66(11):968. PubMed ID: 19451600
[No Abstract] [Full Text] [Related]
20. Etanercept: new indication. For ankylosing spondylitis: another option.
Prescrire Int; 2005 Jun; 14(77):92-3. PubMed ID: 15981387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
